Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda-approvals entities : Gilead sciences, inc. save search
FDA Approves Veklury® (Remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment
Published: 2023-08-24 (Crawled : 18:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: 0.27%
H: 1.15%
C: -1.19%
covid-19 veklury fda treat
FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis
Published: 2023-07-14 (Crawled : 14:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -0.13%
H: 1.34%
C: 0.76%
covid-19 veklury fda renal treatment dialysis
U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer
Published: 2023-02-03 (Crawled : 19:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: 4.01%
H: 2.73%
C: -0.18%
trodelvy fda breast cancer her2 metastatic breast cancer
Sunlenca® (lenacapavir) Receives FDA Approval as a First-in-Class, Twice-Yearly Treatment Option for People Living With Multi-Drug Resistant HIV
Published: 2022-12-22 (Crawled : 18:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -0.03%
H: 0.26%
C: 0.04%
sunlenca treatment fda hiv approval living
Kite Receives U.S. FDA Approval of Viral Vector Manufacturing Facility in Southern California to Produce Commercial Product
Published: 2022-10-03 (Crawled : 14:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: 1.15%
H: 0.27%
C: -0.13%
fda california commercial approval
Kite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland
Published: 2022-04-19 (Crawled : 13:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
fda t-cell approval therapy
HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention
Published: 2021-12-21 (Crawled : 22:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: 0.0%
H: 0.17%
C: -0.87%
fda health thc approval injection hiv
U.S. Food and Drug Administration Approves Expanded Indication of Gilead’s Biktarvy® for Treatment of HIV-1 in Pediatric Populations
Published: 2021-10-18 (Crawled : 13:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -1.83%
H: 0.13%
C: -2.37%
food treatment drug hiv xin
U.S. FDA Approves Kite’s Tecartus® as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Published: 2021-10-01 (Crawled : 00:20) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: 0.0%
fda leukemia fda approval car-t t-cell
U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy
Published: 2021-03-06 (Crawled : 07:00) - biospace.com/
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
| Email alert
Add to watchlist
fda therapy fda approval
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.